Drug: VANCOMYCIN Injury: Treatment failure Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
117666942 | VANCOMYCIN | Treatment failure | XELLIA PHARMACEUTICALS | 31.00 YR | M | 0 | 20160913 | US |
125380951 | VANCOMYCIN | Treatment failure | BAUSCH AND LOMB | 26.00 YR | M | 0 | 20160707 | AU |
126002422 | VANCOMYCIN | Treatment failure | ASTRAZENECA | 56.00 YR | F | 0 | 20160728 | US |
126056661 | VANCOMYCIN | Treatment failure | XELLIA PHARMACEUTICALS | 38.00 YR | F | 0 | 20160729 | US |
126573152 | VANCOMYCIN | Treatment failure | AVENTIS | 40.00 YR | M | 0 | 20160907 | CN |
126829161 | Vancomycin | Treatment failure | CIPLA | 0.00 | 0 | 20160825 | US | |
127028581 | Vancomycin | Treatment failure | VIIV | 0.00 | F | 0 | 20160831 | MZ |
127029621 | Vancomycin | Treatment failure | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160831 | MZ |
127452881 | Vancomycin | Treatment failure | AUROBINDO | 31.00 YR | M | 0 | 20160915 | US |
Total Records: 9 Number of Pages: 1